Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
RenaZorb (SPI-014)
print preview
bookmark
share with colleague
General Information
Company
Spectrum Pharmaceuticals Inc.
Description
Second generation lanthanum-based phosphate-binding agent
Molecular Target
Not available
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Hyperphosphatemia
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy